Filing Details
- Accession Number:
- 0000874015-18-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-17 21:21:12
- Reporting Period:
- 2018-01-14
- Accepted Time:
- 2018-01-17 21:21:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537529 | P Brett Monia | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-15 | 6,985 | $0.00 | 18,604 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 2,821 | $51.76 | 15,783 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2018-01-14 | 30,000 | $0.00 | 30,000 | $53.22 |
| Common Stock | Restricted Stock Units | Acquisiton | 2018-01-15 | 12,916 | $0.00 | 12,916 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2018-01-15 | 6,667 | $0.00 | 6,667 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-01-15 | 6,985 | $0.00 | 6,985 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2019-01-14 | 2025-01-13 | No | 4 | A | Direct |
| 12,916 | No | 4 | A | Direct | ||
| 6,667 | No | 4 | A | Direct | ||
| 10,703 | No | 4 | M | Direct |
Footnotes
- Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
- The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.759 to $51.761, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- Grant of 1/14/2018 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/14/2019. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 7,500 shares per year. Following this transaction, the option was exercisable as to 0 on 1/14/2018.
- Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan.
Billionaire Hedge Funds
